The Role of Concomitant Diseases in Postoperative Complications Risk Stratification.
Launched by RUSSIAN FEDERATION OF ANESTHESIOLOGISTS AND REANIMATOLOGISTS · May 9, 2019
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking into how other health conditions, like heart disease or diabetes, can affect the risk of complications after abdominal surgery. Researchers want to understand how common these additional health issues are among patients and find out which ones might make surgery riskier. By doing this, they hope to better predict who might face challenges after their surgery and improve care for those individuals.
To join this study, participants should be between the ages of 65 and 74 and must be scheduled for surgery on their abdominal organs. They should also have a certain level of health that is assessed using a classification system. People who have severe complications or certain emergencies will not be eligible for this trial. Those who participate can expect to be part of a study that aims to identify important factors that may affect their recovery, helping doctors provide safer and more tailored care.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • surgical interventions on the abdominal organs,
- • 1-3 ASA physical status class
- Exclusion Criteria:
- • the inability to assess the factors included in the study,
- • acute massive blood loss, aspiration,
- • bronchospasm,
- • anaphylactic reactions,
- • malignant hyperthermia
About Russian Federation Of Anesthesiologists And Reanimatologists
The Russian Federation of Anesthesiologists and Reanimatologists is a leading professional organization dedicated to advancing the fields of anesthesia and critical care medicine in Russia. Committed to enhancing clinical practice through research and education, the Federation sponsors clinical trials aimed at improving patient outcomes and safety in anesthesia and resuscitation. By fostering collaboration among healthcare professionals, promoting evidence-based practices, and facilitating the dissemination of innovative techniques, the Federation plays a pivotal role in shaping the future of anesthesiology and critical care in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kazan, , Russian Federation
Nizhny Novgorod, , Russian Federation
Kemerovo, , Russian Federation
Rostov On Don, , Russian Federation
Krasnodar, , Russian Federation
Krasnoyarsk, , Russian Federation
Chelyabinsk, , Russian Federation
Stavropol', , Russian Federation
Astrakhan, , Russian Federation
Novosibirsk, , Russian Federation
Orenburg, , Russian Federation
Chelyabinsk, , Russian Federation
Chita, , Russian Federation
Ekaterinburg, , Russian Federation
Ekaterinburg, , Russian Federation
Kazan, , Russian Federation
Krasnodar, , Russian Federation
Krasnodar, , Russian Federation
Moscow, , Russian Federation
Moscow, , Russian Federation
Moscow, , Russian Federation
Moscow, , Russian Federation
Moscow, , Russian Federation
Moscow, , Russian Federation
Moscow, , Russian Federation
Moscow, , Russian Federation
Petrozavodsk, , Russian Federation
Saint Petersburg, , Russian Federation
Saint Petersburg, , Russian Federation
Samara, , Russian Federation
Saratov, , Russian Federation
Vladivostok, , Russian Federation
Volgograd, , Russian Federation
Volgograd, , Russian Federation
Arkhangel'sk, , Russian Federation
Moscow, , Russian Federation
Tyumen, , Russian Federation
Yakutsk, , Russian Federation
Patients applied
Trial Officials
Igor Zabolotskikh, MD
Principal Investigator
Russian Federation of Anesthesiologists and Reanimatologists
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials